UroGen Pharma Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-6.66 | -268.1 | -97.52% | -3.26 | +104.36% |
| P/S |
|
4.99 | 55.96 | -91.08% |
|
|
| P/BV |
|
-51.24 | 251.23 | -120.4% |
|
|
| P/FCF |
|
-8.71 | -196.64 | -95.57% |
|
|
| Ev/Ebitda |
|
-3.65 | 12.23 | -129.82% |
|
|
| Ev/S |
|
4.45 | 457.86 | -99.03% |
|
|
| Ev/FCF |
|
-4.15 | -232.19 | -98.21% |
|
|
| E/P |
|
-0.1501 | 0.0224 | -771.16% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-122.05 | -341.3 | -64.24% | -118.89 | +2.66% |
| ROE |
|
342.83 | 103.63 | 230.81% |
|
|
| ROA |
|
-54.68 | -2.84 | 1826.82% |
|
|
| ROIC |
|
0 | 1.17 | -100% |
|
|
| ROS |
|
-140.35 | -298.77 | -53.02% |
|
|
| ROCE |
|
1266.85 | -0.0718 | -1764525.19% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-1.12 | 0.9431 | -218.57% | -1.03 | +8.1% |
| Nеt Debt/Ebitda |
|
0.4405 | 1.03 | -57.03% |
|
|
| Debt/Ratio |
|
0.4319 | 0.1785 | 141.9% |
|
|
| Debt/Equity |
|
-33.46 | 1.56 | -2251.39% |
|
|
| Debt/Net Income |
|
-0.9725 | -1.48 | -34.3% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5195 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8444 | -100% | ||
| DSI |
|
0 | 0.2147 | -100% |
|
|
| Average dividend growth |
|
0 | 1.27 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.5087 | -100% |
|
|
| Average percentage for payments |
|
0 | 59.63 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5195 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
666.08 | -87.95 | -857.34% | ||
| Growth impulse Ebitda in 5 years |
|
-12.92 | -156.19 | -91.73% | ||
| Growth impulse Net Income in 5 years |
|
-1.27 | -172.49 | -99.26% | ||
| Growth impulse FCF in 5 years |
|
-9.37 | -114.74 | -91.83% | ||
| Growth impulse EPS in 5 years |
|
-49.85 | -98.04 | -49.15% |
IP Score
3.87/10
